|Salary:||£37,873 to £45,720 UCL Grade 7, per annum , inclusive of London Allowance|
|Placed On:||23rd September 2022|
|Closes:||5th October 2022|
Interview Date: TBC
Full time, Fixed Term: The position is funded for a period of 24 months in the first instance.
Applications are invited for a Research Fellow to join the research team led by Prof Claire Booth. The post-holder will work on the development of novel gene engineering and gene editing approaches to treat XIAP deficiency and it is anticipated that the project will work towards pre-clinical validation in readiness for early phase clinical trials. Work in the laboratory includes the use of in vivo and in vitro animal models, human cell lines, and human primary cells. The post-holder will design viral vectors and CRISR guides and generate gene edited primary cells prior to functional validation of gene-edited cells in relevant model systems. The post is ideal for a motivated postdoctoral scientist who enjoys working as a member of a committed team with multiple local and international collaborators.
The position is funded for a period of 24 months in the first instance.
The post holder should have a PhD in a relevant subject and prior knowledge and experience in molecular and cellular biology techniques and human cell culture. Evidence of scientific contribution including publications is essential.
Applicants should apply online. To access further details about the position and how to apply please click on the ‘Apply’ button above.
If you have any queries regarding the application process, please contact Madhur Sharma on firstname.lastname@example.org quoting job reference 1887529.
Latest time for the submission of applications: 23:59
UCL Taking Action for Equality
Our department holds an Athena SWAN Gold award, in recognition of our long-term commitment and 'beacon' status in advancing gender equality.
Type / Role: